Noxopharm Ltd. engages in the research and development of drugs. It focuses on sensitizing cancer cells to radiotherapy and chemotherapy. The company was founded by Graham Kelly on October 27, 2015 and is headquartered in Chatswood, Australia.
NOX stock has fallen by 6.15% compared to the previous week, the month change is a 11.59% fall, over the last year NOXOPHARM LIMITED has showed a 3.17% decrease.
NOX net income for the last quarter is −2.50 M AUD, while the quarter before that showed −9.63 M AUD of net income which accounts for 74.06% change. Track more NOXOPHARM LIMITED financial stats to get the full picture.
Today NOXOPHARM LIMITED has the market capitalization of 17.83 M, it has decreased by 14.29% over the last week.
No, NOX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NOX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOXOPHARM LIMITED stock right from TradingView charts — choose your broker and connect to your account.
NOX reached its all-time high on Dec 14, 2017 with the price of 1.590 AUD, and its all-time low was 0.033 AUD and was reached on Sep 8, 2023. See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOXOPHARM LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOXOPHARM LIMITED stock shows the sell signal. See more of NOXOPHARM LIMITED technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.